Case Study: Creating and Closing Processes for Next-Generation Cas9-Engineered T Cell Therapies with Large Payloads

Time: 9:30 am
day: Day One


• Integrating large modules and circuits into T cells with DNA plasmid vectors and Cas9 engineering
• Closing processes to increase sterility, process control, and safety
• Discussing the challenges of leveraging novel engineering technologies in process development, and sharing lessons learned so far